Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Disease Areas » Infectious Disease » Accelerate Diagnostics Preliminary Q4 Revenues Rise 94 Percent

Accelerate Diagnostics Preliminary Q4 Revenues Rise 94 Percent

Jan 13, 2020
|
staff reporter

NEW YORK – Accelerate Diagnostics reported on Monday that its preliminary fourth quarter revenues rose 94 percent but still fell short of the company's expectations.

For the quarter ended December 30, 2019 Accelerate Diagnostics expects total revenues of $3.5 million, up from $1.8 million in the year-ago quarter. For the full year, total revenue is expected to be $9.3 million, up 63 percent compared to its full-year 2018 revenues of $5.7 million.

The analysts' average estimates were for Q4 revenues of $4.8 million and for full-year revenues of $10.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Keep It (Partly) Virtual

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

For Cross-Protection

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Proteomics of Severity

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

Genome Biology Papers on Regulatory Element, Single-Cell Integration, Sequence Simulation Tools

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.

Mar
11
Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

Sponsored by
Foundation Medicine

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar
17
Featured Webinar

Spatial Profiling of Metabolic Regulation in the Human Tumor Microenvironment Using Multiplexed Ion Beam Imaging

Sponsored by
IONPath

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.

Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
25
Featured Webinar

Virtual Molecular Tumor Board Series: What to Do with a ‘Negative’ Molecular Panel Case

Sponsored by
Foundation Medicine

In this session, the fourth in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling identified no clear molecular markers to help guide personalized therapy.

What's Popular?

In Infectious Disease

  1. Hologic Acquires European MDx Firm Diagenode for Approximately $159M

  2. Host DNA Methylation Signatures May Predict Likelihood of Persistent, Resolving MRSA Infections

  3. Luminex Shares Surge on Rumor of Acquisition by DiaSorin

  4. FDA Grants Emergency Use Authorization for University of Illinois Coronavirus PCR Test

  5. GenMark Diagnostics Seeing Continued Demand for Respiratory Panels, Plans 510(k) Submission

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.